Close this search box.

Seventeen Minutes of Science: Tiny Worms With a Big Impact; Using C. elegans for Toxicology Studies

Tune in weekly to our virtual series “Seventeen Minutes of Science” every Tuesday at 11am PST / 2pm ET where we go live on Facebook with a new guest each week to talk about how science and biotechnology is woven into their lives for (you guessed it) 17 minutes!

For episode 28 of 17 Minutes of Science, we are joined by Kyle Galford to discuss his recent publication, The FDA-approved drugs ticlopidine, sertaconazole, and dexlansoprazole can cause morphological changes in C. elegans.

Kyle is a recent graduate of the University of Maryland (Spring 2019) where he worked with Dr. Antony Jose to conduct this research. Kyle now holds a sales position with Novogene. Kyle joins us to discuss the key findings of his research and why C. elegans were the ideal model for this study.

Learn more about toxicity testing

About The Author

InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.

Share this articles

Picture of InVivo Biosystems

About the Author:

Connect with us